OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,595,000 | -23.2% | 370,900 | -90.0% | 0.08% | -39.9% |
| Q1 2016 | $2,077,000 | -67.4% | 3,709,000 | 0.0% | 0.14% | -66.0% |
| Q4 2015 | $6,379,000 | -18.5% | 3,709,000 | 0.0% | 0.41% | -21.3% |
| Q3 2015 | $7,826,000 | -57.4% | 3,709,000 | 0.0% | 0.52% | -46.2% |
| Q2 2015 | $18,360,000 | -36.8% | 3,709,000 | 0.0% | 0.96% | -27.0% |
| Q1 2015 | $29,041,000 | +29.2% | 3,709,000 | 0.0% | 1.31% | +20.5% |
| Q4 2014 | $22,477,000 | +42.3% | 3,709,000 | 0.0% | 1.09% | +35.7% |
| Q3 2014 | $15,800,000 | +32.1% | 3,709,000 | +91.6% | 0.80% | +43.1% |
| Q2 2014 | $11,960,000 | -4.9% | 1,935,300 | 0.0% | 0.56% | -9.2% |
| Q1 2014 | $12,579,000 | +15.4% | 1,935,300 | 0.0% | 0.62% | +17.5% |
| Q4 2013 | $10,896,000 | +53.9% | 1,935,300 | +67.5% | 0.53% | +87.2% |
| Q3 2013 | $7,082,000 | – | 1,155,300 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |